
Nancy J. Leith
Examiner (ID: 12198, Phone: (313)446-4874 , Office: P/1636 )
| Most Active Art Unit | 1636 |
| Art Unit(s) | 1636, 1811, 1815, 1941, 1805 |
| Total Applications | 1445 |
| Issued Applications | 999 |
| Pending Applications | 194 |
| Abandoned Applications | 284 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 11115269
[patent_doc_number] => 20160312242
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-10-27
[patent_title] => 'CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON'
[patent_app_type] => utility
[patent_app_number] => 15/104785
[patent_app_country] => US
[patent_app_date] => 2014-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 11876
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 15
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15104785
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/104785 | CANCER IMMUNOTHERAPY BY DELIVERING CLASS II MHC ANTIGENS USING A VLP-REPLICON | Dec 15, 2014 | Abandoned |
Array
(
[id] => 10267463
[patent_doc_number] => 20150152460
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES'
[patent_app_type] => utility
[patent_app_number] => 14/564084
[patent_app_country] => US
[patent_app_date] => 2014-12-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 49
[patent_figures_cnt] => 49
[patent_no_of_words] => 38223
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14564084
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/564084 | METHODS AND COMPOSITIONS FOR SEAMLESS CLONING OF NUCLEIC ACID MOLECULES | Dec 7, 2014 | Abandoned |
Array
(
[id] => 10219440
[patent_doc_number] => 20150104433
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-16
[patent_title] => 'TAILORED RECOMBINASE FOR RECOMBINING ASYMMETRIC TARGET SITES IN A PLURALITY OF RETROVIRUS STRAINS'
[patent_app_type] => utility
[patent_app_number] => 14/560795
[patent_app_country] => US
[patent_app_date] => 2014-12-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 19826
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14560795
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/560795 | TAILORED RECOMBINASE FOR RECOMBINING ASYMMETRIC TARGET SITES IN A PLURALITY OF RETROVIRUS STRAINS | Dec 3, 2014 | Abandoned |
Array
(
[id] => 10267396
[patent_doc_number] => 20150152393
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'Avian Adenoassociated Virus and Uses Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/554728
[patent_app_country] => US
[patent_app_date] => 2014-11-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 23215
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14554728
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/554728 | Avian adenoassociated virus and uses thereof | Nov 25, 2014 | Issued |
Array
(
[id] => 10254978
[patent_doc_number] => 20150139975
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'RECOMBINANT FACTOR H AND VARIANTS AND CONJUGATES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/541834
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 11863
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14541834
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/541834 | RECOMBINANT FACTOR H AND VARIANTS AND CONJUGATES THEREOF | Nov 13, 2014 | Abandoned |
Array
(
[id] => 16573657
[patent_doc_number] => 10895575
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-01-19
[patent_title] => Method for identification, selection and analysis of tumour cells
[patent_app_type] => utility
[patent_app_number] => 14/542259
[patent_app_country] => US
[patent_app_date] => 2014-11-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 25
[patent_no_of_words] => 10638
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 522
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14542259
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/542259 | Method for identification, selection and analysis of tumour cells | Nov 13, 2014 | Issued |
Array
(
[id] => 10256365
[patent_doc_number] => 20150141362
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-21
[patent_title] => 'Inhibitors of Human EZH2, and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 14/540977
[patent_app_country] => US
[patent_app_date] => 2014-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 25561
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14540977
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/540977 | Inhibitors of human EZH2, and methods of use thereof | Nov 12, 2014 | Issued |
Array
(
[id] => 11313137
[patent_doc_number] => 20160349246
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-12-01
[patent_title] => 'SEPARATION METHOD, DETECTION METHOD, SIGNAL MEASUREMENT METHOD, METHOD FOR DETERMINING DISEASE, METHOD FOR EVALUATING DRUG EFFICACY OF DISEASE TREATMENT DRUG, KIT, AND LIQUID COMPOSITION'
[patent_app_type] => utility
[patent_app_number] => 15/035094
[patent_app_country] => US
[patent_app_date] => 2014-11-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 13867
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15035094
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/035094 | Separation method, detection method, signal measurement method, method for determining disease, method for evaluating drug efficacy of disease treatment drug, kit, and liquid composition | Nov 5, 2014 | Issued |
Array
(
[id] => 12086995
[patent_doc_number] => 09840713
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'CRISPR-Cas component systems, methods and compositions for sequence manipulation'
[patent_app_type] => utility
[patent_app_number] => 14/523799
[patent_app_country] => US
[patent_app_date] => 2014-10-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 116
[patent_figures_cnt] => 117
[patent_no_of_words] => 55019
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14523799
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/523799 | CRISPR-Cas component systems, methods and compositions for sequence manipulation | Oct 23, 2014 | Issued |
Array
(
[id] => 12037847
[patent_doc_number] => 09816068
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-14
[patent_title] => 'Separatome-based protein expression and purification platform'
[patent_app_type] => utility
[patent_app_number] => 14/521845
[patent_app_country] => US
[patent_app_date] => 2014-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 24879
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 535
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14521845
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/521845 | Separatome-based protein expression and purification platform | Oct 22, 2014 | Issued |
Array
(
[id] => 11042648
[patent_doc_number] => 20160239604
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'METHOD FOR IMPROVING THE SENSITIVITY OF DETECTION IN DETERMINING COPY NUMBER VARIATIONS'
[patent_app_type] => utility
[patent_app_number] => 15/031246
[patent_app_country] => US
[patent_app_date] => 2014-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 47888
[patent_no_of_claims] => 45
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15031246
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/031246 | Method for improving the sensitivity of detection in determining copy number variations | Oct 20, 2014 | Issued |
Array
(
[id] => 11062920
[patent_doc_number] => 20160259883
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-09-08
[patent_title] => 'SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION'
[patent_app_type] => utility
[patent_app_number] => 15/030370
[patent_app_country] => US
[patent_app_date] => 2014-10-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 39506
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 25
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15030370
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/030370 | SENSE-ANTISENSE GENE PAIRS FOR PATIENT STRATIFICATION, PROGNOSIS, AND THERAPEUTIC BIOMARKERS IDENTIFICATION | Oct 19, 2014 | Abandoned |
Array
(
[id] => 16925511
[patent_doc_number] => 11046975
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-06-29
[patent_title] => Bicistronic expression vector for antibody expression and method for producing antibody using same
[patent_app_type] => utility
[patent_app_number] => 15/027929
[patent_app_country] => US
[patent_app_date] => 2014-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 14
[patent_no_of_words] => 13087
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 157
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15027929
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/027929 | Bicistronic expression vector for antibody expression and method for producing antibody using same | Oct 6, 2014 | Issued |
Array
(
[id] => 9839009
[patent_doc_number] => 20150031090
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'METHODS AND COMPOSITIONS FOR TARGETED GENOMIC DELETION'
[patent_app_type] => utility
[patent_app_number] => 14/502773
[patent_app_country] => US
[patent_app_date] => 2014-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 14784
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14502773
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/502773 | Methods and compositions for targeted genomic deletion | Sep 29, 2014 | Issued |
Array
(
[id] => 9839055
[patent_doc_number] => 20150031134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-01-29
[patent_title] => 'CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION'
[patent_app_type] => utility
[patent_app_number] => 14/497627
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 118
[patent_figures_cnt] => 118
[patent_no_of_words] => 55009
[patent_no_of_claims] => 28
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14497627
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/497627 | CRISPR-CAS COMPONENT SYSTEMS, METHODS AND COMPOSITIONS FOR SEQUENCE MANIPULATION | Sep 25, 2014 | Abandoned |
Array
(
[id] => 10267143
[patent_doc_number] => 20150152141
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-06-04
[patent_title] => 'CYTOKINE'
[patent_app_type] => utility
[patent_app_number] => 14/498317
[patent_app_country] => US
[patent_app_date] => 2014-09-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 21405
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14498317
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/498317 | Cytokine | Sep 25, 2014 | Issued |
Array
(
[id] => 11011286
[patent_doc_number] => 20160208239
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-21
[patent_title] => 'EXPRESSION VECTOR PRODUCTION AND HIGH-THROUGHPUT CELL SCREENING'
[patent_app_type] => utility
[patent_app_number] => 14/917236
[patent_app_country] => US
[patent_app_date] => 2014-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 22261
[patent_no_of_claims] => 50
[patent_no_of_ind_claims] => 35
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14917236
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/917236 | Expression vector production and high-throughput cell screening | Sep 17, 2014 | Issued |
Array
(
[id] => 12044778
[patent_doc_number] => 09822371
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-11-21
[patent_title] => 'E. coli separatome-based protein expression and purification platform'
[patent_app_type] => utility
[patent_app_number] => 15/022852
[patent_app_country] => US
[patent_app_date] => 2014-09-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 18
[patent_no_of_words] => 47221
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15022852
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/022852 | E. coli separatome-based protein expression and purification platform | Sep 16, 2014 | Issued |
Array
(
[id] => 9909586
[patent_doc_number] => 20150064787
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-05
[patent_title] => 'Host Cell Modification with Artificial Endosymbionts'
[patent_app_type] => utility
[patent_app_number] => 14/476584
[patent_app_country] => US
[patent_app_date] => 2014-09-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 35
[patent_figures_cnt] => 35
[patent_no_of_words] => 18302
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14476584
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/476584 | Host cell modification with artificial endosymbionts | Sep 2, 2014 | Issued |
Array
(
[id] => 10671156
[patent_doc_number] => 20160017301
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-01-21
[patent_title] => 'METHODS AND COMPOSITIONS FOR RNA-GUIDED TREATMENT OF HIV INFECTION'
[patent_app_type] => utility
[patent_app_number] => 14/838057
[patent_app_country] => US
[patent_app_date] => 2014-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 24052
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14838057
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/838057 | Methods and compositions for RNA-guided treatment of HIV infection | Aug 28, 2014 | Issued |